Optimal designs for clinical trials with dichotomous responses
- PMID: 4089351
- DOI: 10.1002/sim.4780040410
Optimal designs for clinical trials with dichotomous responses
Abstract
We consider two-stage designs for clinical trials that involve two treatments with dichotomous responses. The first is the information-gathering stage; the treatment chosen as the better from first stage and prior data is used exclusively in the second stage. Determination of treatment allocation in the first stage results from weighing the anticipated gain in information with effective treatment; the objective is to maximize the expected number of successes in the entire trial. This is in contrast to randomized controlled trials with the restricted objective of obtaining information concerning treatment differences. We allow the length of the first stage to be arbitrary and fixed in advance, or optimized as a function of prior information and the 'patient horizon'. We can regard this patient horizon as either the number of patients in the trial or the number who have the condition under treatment. We consider two forms of prior information: both success probabilities known but the better of the two treatments is unknown, and one success probability known whereas the other has an arbitrary distribution. In many instances of the latter case the optimal first stage size is of the order of the square root of the patient horizon.
Similar articles
-
Implementing a decision-theoretic design in clinical trials: why and how?Stat Med. 2007 Nov 30;26(27):4939-57. doi: 10.1002/sim.2949. Stat Med. 2007. PMID: 17582801
-
Optimal two-stage designs for clinical trials with binary response.Stat Med. 1988 May;7(5):571-9. doi: 10.1002/sim.4780070504. Stat Med. 1988. PMID: 3387716
-
Statistical inference and the design of clinical trials.Biomedicine. 1980 Feb;32(1):4-7. Biomedicine. 1980. PMID: 7370380
-
Adaptive designs: The Swiss Army knife among clinical trial designs?Clin Trials. 2017 Oct;14(5):417-424. doi: 10.1177/1740774517699406. Epub 2017 Mar 22. Clin Trials. 2017. PMID: 28982262 Review.
-
The advantages and disadvantages of adaptive designs for clinical trials.Drug Discov Today. 2004 Apr 15;9(8):351-7. doi: 10.1016/S1359-6446(04)03023-5. Drug Discov Today. 2004. PMID: 15081962 Review.
Cited by
-
Bayesian optimal design for phase II screening trials.Biometrics. 2008 Sep;64(3):886-894. doi: 10.1111/j.1541-0420.2007.00951.x. Epub 2007 Dec 20. Biometrics. 2008. PMID: 18162113 Free PMC article.
-
Dynamic Learning of Patient Response Types: An Application to Treating Chronic Diseases.Manage Sci. 2018 Aug;64(8):3469-3970. doi: 10.1287/mnsc.2017.2793. Epub 2017 Aug 21. Manage Sci. 2018. PMID: 30344343 Free PMC article.
Publication types
MeSH terms
LinkOut - more resources
Medical